BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Nov 24, 2008
 |  BC Week In Review  |  Clinical News  |  Regulatory

Victoza liraglutide regulatory update

Novo Nordisk said FDA rescheduled the March 2 meeting of the Endocrinologic and Metabolic Drugs Advisory Committee to discuss an NDA for once-daily liraglutide...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >